Blockchain Registration Transaction Record

Urine Test Detects Bladder Cancer After Surgery, Monitors Immunotherapy

New urine test detects bladder cancer recurrence after surgery and monitors immunotherapy response. Learn how this non-invasive liquid biopsy could transform patient care.

This news matters because it introduces a non-invasive urine test that could revolutionize bladder cancer management by enabling early detection of residual disease after surgery and monitoring immunotherapy effectiveness. For patients, this means potentially fewer invasive procedures and more personalized treatment adjustments. For the biotech industry, it highlights the growing role of liquid biopsies in oncology and underscores the importance of companies like Calidi Biotherapeutics in developing targeted immunotherapies.